114 related articles for article (PubMed ID: 8657913)
1. Percutaneous biopsy for prognostic testing of neuroblastoma.
Hoffer FA; Chung T; Diller L; Kozakewich H; Fletcher JA; Shamberger RC
Radiology; 1996 Jul; 200(1):213-6. PubMed ID: 8657913
[TBL] [Abstract][Full Text] [Related]
2. Needle core vs open biopsy for diagnosis of intermediate- and high-risk neuroblastoma in children.
Hassan SF; Mathur S; Magliaro TJ; Larimer EL; Ferrell LB; Vasudevan SA; Patterson DM; Louis CU; Russell HV; Nuchtern JG; Kim ES
J Pediatr Surg; 2012 Jun; 47(6):1261-6. PubMed ID: 22703803
[TBL] [Abstract][Full Text] [Related]
3. Assessment of percutaneous fine needle aspiration cytology as a technique to provide diagnostic and prognostic information in neuroblastoma.
Thiesse P; Hany MA; Combaret V; Ranchère-Vince D; Bouffet E; Bergeron C
Eur J Cancer; 2000 Aug; 36(12):1544-51. PubMed ID: 10930802
[TBL] [Abstract][Full Text] [Related]
4. The use of fine-needle aspiration cytology in the molecular characterization of neuroblastoma in children.
Fröstad B; Martinsson T; Tani E; Falkmer U; Darnfors C; Skoog L; Kogner P
Cancer; 1999 Apr; 87(2):60-8. PubMed ID: 10227595
[TBL] [Abstract][Full Text] [Related]
5. Lack of correlation of N-myc gene amplification with prognosis in localized neuroblastoma: a Pediatric Oncology Group study.
Cohn SL; Look AT; Joshi VV; Holbrook T; Salwen H; Chagnovich D; Chesler L; Rowe ST; Valentine MB; Komuro H
Cancer Res; 1995 Feb; 55(4):721-6. PubMed ID: 7850780
[TBL] [Abstract][Full Text] [Related]
6. Analysis of needle versus open biopsy for the diagnosis of advanced stage pediatric neuroblastoma.
Gupta A; Kumar A; Walters S; Chait P; Irwin MS; Gerstle JT
Pediatr Blood Cancer; 2006 Dec; 47(7):875-9. PubMed ID: 16276526
[TBL] [Abstract][Full Text] [Related]
7. DNA ploidy in neuroblastoma.
Eckschlager T; Pilát D; Kodet R; Dahbiová R; Stanková J; Jasinská J; Hrusák O
Neoplasma; 1996; 43(1):23-6. PubMed ID: 8843955
[TBL] [Abstract][Full Text] [Related]
8. Hyperdiploidy plus nonamplified MYCN confers a favorable prognosis in children 12 to 18 months old with disseminated neuroblastoma: a Pediatric Oncology Group study.
George RE; London WB; Cohn SL; Maris JM; Kretschmar C; Diller L; Brodeur GM; Castleberry RP; Look AT
J Clin Oncol; 2005 Sep; 23(27):6466-73. PubMed ID: 16116152
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the prognostic factors relating to better clinical outcome in ganglioneuroblastoma.
Kubota M; Suita S; Tajiri T; Shono K; Fujii Y
J Pediatr Surg; 2000 Jan; 35(1):92-5. PubMed ID: 10646782
[TBL] [Abstract][Full Text] [Related]
10. Open versus needle biopsy in diagnosing neuroblastoma.
Mullassery D; Sharma V; Salim A; Jawaid WB; Pizer BL; Abernethy LJ; Losty PD
J Pediatr Surg; 2014 Oct; 49(10):1505-7. PubMed ID: 25280656
[TBL] [Abstract][Full Text] [Related]
11. [Value of prognostic factors in the Austrian A-NB87 Neuroblastoma Study].
Ladenstein R; Ambros PF; Urban C; Ambros IM; Fink FM; Zoubek A; Grienberger H; Schmitt K; Kerbl R; Horcher E; Amann G; Höfler G; Heinzl H; Gadner H; Mutz I
Klin Padiatr; 1996; 208(4):210-20. PubMed ID: 8926686
[TBL] [Abstract][Full Text] [Related]
12. Combined analysis of DNA ploidy index and N-myc genomic content in neuroblastoma.
Bourhis J; Bénard J; DeVathaire F; Wilson GD; Hartmann O; Terrier-Lacombe MJ; Boccon-Gibod L; Lemerle J; Riou G
Prog Clin Biol Res; 1991; 366():107-13. PubMed ID: 2068130
[No Abstract] [Full Text] [Related]
13. [N-myc status of neuroblastoma from bone marrow cells].
Brack T; Finckenstein FG; Kabisch H
Klin Padiatr; 1991; 203(4):323-7. PubMed ID: 1942939
[TBL] [Abstract][Full Text] [Related]
14. Analysis of DNA ploidy and proliferative activity in relation to histology and N-myc amplification in neuroblastoma.
Cohn SL; Rademaker AW; Salwen HR; Franklin WA; Gonzales-Crussi F; Rosen ST; Bauer KD
Am J Pathol; 1990 May; 136(5):1043-52. PubMed ID: 2349963
[TBL] [Abstract][Full Text] [Related]
15. Competitive polymerase chain reaction for the determination of N-myc amplification in neuroblastoma: report of clinical cases.
Hasan Z; Inoue A; Ikeda H; Kamii Y; Obana K; Yokomori K; Tsuchida Y; Hemmi H; Shimatake H
Eur J Pediatr Surg; 1999 Jun; 9(3):138-41. PubMed ID: 10427487
[TBL] [Abstract][Full Text] [Related]
16. Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma.
Bown N; Cotterill S; Lastowska M; O'Neill S; Pearson AD; Plantaz D; Meddeb M; Danglot G; Brinkschmidt C; Christiansen H; Laureys G; Speleman F; Nicholson J; Bernheim A; Betts DR; Vandesompele J; Van Roy N
N Engl J Med; 1999 Jun; 340(25):1954-61. PubMed ID: 10379019
[TBL] [Abstract][Full Text] [Related]
17. Proliferation marker KI-S5 discriminates between favorable and adverse prognosis in advanced stages of neuroblastoma with and without MYCN amplification.
Krams M; Hero B; Berthold F; Parwaresch R; Harms D; Rudolph P
Cancer; 2002 Feb; 94(3):854-61. PubMed ID: 11857322
[TBL] [Abstract][Full Text] [Related]
18. Optimization of percutaneous biopsy for diagnosis and pretreatment risk assessment of neuroblastoma.
Overman RE; Kartal TT; Cunningham AJ; Fialkowski EA; Naik-Mathuria BJ; Vasudevan SA; Malek MM; Kalsi R; Le HD; Stafford LC; Lautz TB; Many BT; Jones RE; Bütter A; Davidson J; Williams A; Dasgupta R; Lewis J; Troutt M; Aldrink JH; Mansfield SA; Lal DR; Xiao J; Meyers RL; Short SS; Newman EA
Pediatr Blood Cancer; 2020 May; 67(5):e28153. PubMed ID: 32072730
[TBL] [Abstract][Full Text] [Related]
19. MYCN protein expression as a predictor of neuroblastoma prognosis.
Chan HS; Gallie BL; DeBoer G; Haddad G; Ikegaki N; Dimitroulakos J; Yeger H; Ling V
Clin Cancer Res; 1997 Oct; 3(10):1699-706. PubMed ID: 9815553
[TBL] [Abstract][Full Text] [Related]
20. [Activation of N-myc oncogene and associated genes to chemoresistance, prognostic value for neuroblastoma].
Bénard J; Bourhis J; Riou G
Bull Cancer; 1991 Jan; 78(1):91-7. PubMed ID: 2021689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]